Association of Foxp3 regulatory gene expression with graft-versus-host disease

被引:251
作者
Miura, Y
Thoburn, CJ
Bright, EC
Phelps, ML
Shin, T
Matsui, EC
Matsui, WH
Arai, S
Fuchs, EJ
Vogelsang, GB
Jones, RJ
Hess, AD
机构
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA
[3] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
D O I
10.1182/blood-2004-03-1040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is characterized by an impairment of mechanisms that underlie the development of immunologic tolerance. Although the cytokine storm associated with GVHD leads to expression of cell surface markers on both effector and regulatory T cells, regulatory CD4(+) T cells that play an instrumental role in the maintenance of tolerance appear to uniquely express the Foxp3 transcriptional repressor. Foxp3 mRNA expression was significantly decreased in peripheral blood mononuclear cells from patients with either allogeneic GVHD or autologous GVHD compared with patients without GVHD. Expression of Foxp3 negatively correlated with the severity of GVHD but positively correlated with recent thymic emigrants. The results suggest that defective thymic function contributes to the impaired reconstitution of immune regulatory mechanisms following transplantation. The decrease in regulatory mechanisms after transplantation appears to provide an environment permissive to the development of GVHD. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2187 / 2193
页数:7
相关论文
共 48 条
[1]   Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study [J].
Akpek, G ;
Lee, SJ ;
Flowers, ME ;
Pavletic, SZ ;
Arora, M ;
Lee, S ;
Piantadosi, S ;
Guthrie, KA ;
Lynch, JC ;
Takatu, A ;
Horowitz, MM ;
Antin, JH ;
Weisdorf, DJ ;
Martin, PJ ;
Vogelsang, GB .
BLOOD, 2003, 102 (03) :802-809
[2]   Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells [J].
Bensinger, SJ ;
Bandeira, A ;
Jordan, MS ;
Caton, AJ ;
Laufer, TM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :427-438
[3]   PREVENTION OF SYNGENEIC GRAFT-VERSUS-HOST DISEASE BY RECOVERY OF THYMIC MICROENVIRONMENT AFTER CYCLOSPORINE [J].
BESCHORNER, WE ;
REN, H ;
PHILLIPS, J ;
PULIDO, HB ;
HRUBAN, RH ;
HESS, AD .
TRANSPLANTATION, 1991, 52 (04) :668-674
[4]  
BESCHORNER WE, 1978, AM J PATHOL, V92, P173
[5]   Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells [J].
Clark, FJ ;
Gregg, R ;
Piper, K ;
Dunnion, D ;
Freeman, L ;
Griffiths, M ;
Begum, G ;
Mahendra, P ;
Craddock, C ;
Moss, P ;
Chakraverty, R .
BLOOD, 2004, 103 (06) :2410-2416
[6]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[7]   CD4+ Th cells resembling regulatory T cells that inhibit chronic colitis differentiate in the absence of interactions between CD4 and class II MHC [J].
Denning, TL ;
Qi, H ;
König, R ;
Scott, KG ;
Naganuma, M ;
Ernst, PB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (05) :2279-2286
[8]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695
[9]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150
[10]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992